Pfizer reported that its dose-optimization studies of once-daily formulations of danuglipron met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase III testing, based on earlier studies of twice-daily danuglipron
A complete exercise guide covering resistance training, cardio, energy management, and realistic starting points
Read clinical review A physician-reviewed guide to getting Wegovy (semaglutide 2.4 mg) through telehealth: real pricing, candidacy criteria, the STEP-1 trial data, and how compounded semaglutide fits in
Smoothie King, a nationwide fast-food chain, has decided to capitalize on the growing market of Ozempic users with a brand new menu designed with people taking GLP-1 medications in mind
Advanced Uropathology is affiliated with Integrated Medical Professionals, PLLC (IMP), a subsidiary of Solaris Health
Molecules (2018) 23:110